Hubei Biocause Heilen Pharmaceutical Co Ltd (301211)

Shenzhen
Currency in CNY
18.00
+0.14(+0.78%)
Delayed Data·
301211 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
301211 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.7818.12
52 wk Range
13.6025.77
Key Statistics
Edit
Bid/Ask
18.00 / 18.01
Prev. Close
17.86
Open
17.9
Day's Range
17.78-18.12
52 wk Range
13.6-25.77
Volume
2.07M
Average Volume (3m)
5.65M
1-Year Change
24.04%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301211 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Hubei Biocause Heilen Pharmaceutical Co Ltd Company Profile

Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China and internationally. The company provides APIs and intermediates, and formulations; and dimethyl ether gas and a-chloropropionyl chloride chemical products. It is also involved in the contract research, manufacture, and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc. The company was founded in 1995 and is based in Jingmen, China.

Employees
987
Market
China

Compare 301211 to Peers and Sector

Metrics to compare
301211
Peers
Sector
Relationship
P/E Ratio
80.5x28.6x−0.5x
PEG Ratio
−1.30−0.730.00
Price/Book
2.2x2.9x2.6x
Price / LTM Sales
12.3x4.1x3.2x
Upside (Analyst Target)
-9.2%45.3%
Fair Value Upside
Unlock11.8%7.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.23%
Dividend Yield
1.40%
Annualised payout
0.25
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 27, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
114.45M / --
EPS Revisions
Last 90 days

301211 Income Statement

FAQ

What Is the Hubei Biocause Heilen Pharmaceutical (301211) Stock Price Today?

The Hubei Biocause Heilen Pharmaceutical stock price today is 18.00

What Stock Exchange Does Hubei Biocause Heilen Pharmaceutical Trade On?

Hubei Biocause Heilen Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Hubei Biocause Heilen Pharmaceutical?

The stock symbol for Hubei Biocause Heilen Pharmaceutical is "301211."

Does Hubei Biocause Heilen Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Hubei Biocause Heilen Pharmaceutical dividend yield is 1.4%.

What Is the Hubei Biocause Heilen Pharmaceutical Market Cap?

As of today, Hubei Biocause Heilen Pharmaceutical market cap is 5.14B.

What Is Hubei Biocause Heilen Pharmaceutical's Earnings Per Share (TTM)?

The Hubei Biocause Heilen Pharmaceutical EPS (TTM) is 0.23.

From a Technical Analysis Perspective, Is 301211 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Hubei Biocause Heilen Pharmaceutical Stock Split?

Hubei Biocause Heilen Pharmaceutical has split 1 times.

How Many Employees Does Hubei Biocause Heilen Pharmaceutical Have?

Hubei Biocause Heilen Pharmaceutical has 987 employees.

What is the current trading status of Hubei Biocause Heilen Pharmaceutical (301211)?

As of 15 July 2025, Hubei Biocause Heilen Pharmaceutical (301211) is trading at a price of 18.00, with a previous close of 17.86. The stock has fluctuated within a day range of 17.78 to 18.12, while its 52-week range spans from 13.60 to 25.77.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.